South African firm warns of 'pseudo-generics' undermining market for true copycats

Privately-held South African pharma company Pharma Dynamics has warned of the risk of of ‘pseudo-generics’ in the local pharmaceutical market.

The cardio-vascular specialist describes these drugs as ‘clones’ of the branded products, which are marketed under a different name, and designed to fool consumers into thinking they are generic versions.

While less expensive than the original branded version, they could be more expensive than ‘true’ generics.